Intensity Therapeutics, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Intensity Therapeutics, Inc. (INTS) is -55215.00

According to Intensity Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -55215.00. This represents a change of -100.92% compared to the average of 6.00M of the last 4 quarters.

Intensity Therapeutics, Inc. (INTS) Historical Enterprise Value (quarterly & annually)

How has INTS Enterprise Value performed in the past?

The mean historical Enterprise Value of Intensity Therapeutics, Inc. over the last ten years is 21.59M. The current -55215.00 Enterprise Value has changed -100.26% with respect to the historical average. Over the past ten years (40 quarters), INTS's Enterprise Value was at its highest in in the December 2023 quarter at 109.57M. The Enterprise Value was at its lowest in in the June 2021 quarter at 0.

Intensity Therapeutics, Inc. (INTS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Intensity Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Intensity Therapeutics, Inc. (INTS) Average Enterprise Value

How has INTS Enterprise Value performed in the past?

The current Enterprise Value of Intensity Therapeutics, Inc. (INTS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Intensity Therapeutics, Inc. (INTS) Enterprise Value vs. Peers

How is INTS’s Enterprise Value compared to its peers?

Intensity Therapeutics, Inc.’s Enterprise Value is less than Iterum Therapeutics plc (25.39M), greater than Rallybio Corporation (-5519132.00), greater than iBio, Inc. (-3709374.00), less than Pluri Inc. (44.55M), less than Boundless Bio, Inc. (35.06M), less than Sonnet BioTherapeutics Holdings, Inc. (3.36M), less than Plus Therapeutics, Inc. (11.11M), less than NextCure, Inc. (14.84M), less than AN2 Therapeutics, Inc. (121.34M), less than Q32 Bio Inc. (161.00M),

Build a custom stock screener for Intensity Therapeutics, Inc. (INTS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Intensity Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Intensity Therapeutics, Inc. (INTS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Intensity Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.